Your browser doesn't support javascript.
loading
Pretherapeutic 124I dosimetry reliably predicts intratherapeutic blood kinetics of 131I in patients with differentiated thyroid carcinoma receiving high therapeutic activities.
Ruhlmann, Marcus; Sonnenschein, Wilfried; Nagarajah, James; Binse, Ina; Herrmann, Ken; Jentzen, Walter.
Affiliation
  • Ruhlmann M; Department of Nuclear Medicine, University Hospital, University of Duisburg-Essen, Essen.
  • Sonnenschein W; Department of Diagnostic and Interventional Radiology, Medical Faculty, University of Duesseldorf, Duesseldorf, Germany.
  • Nagarajah J; Department of Nuclear Medicine, University Hospital, University of Duisburg-Essen, Essen.
  • Binse I; Department of Nuclear Medicine, University Hospital, University of Duisburg-Essen, Essen.
  • Herrmann K; Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Jentzen W; Department of Nuclear Medicine, University Hospital, University of Duisburg-Essen, Essen.
Nucl Med Commun ; 39(5): 457-464, 2018 May.
Article in En | MEDLINE | ID: mdl-29517576
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Thyroid Neoplasms / Iodine Radioisotopes Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Nucl Med Commun Year: 2018 Type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Thyroid Neoplasms / Iodine Radioisotopes Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Nucl Med Commun Year: 2018 Type: Article